Hooked-wire-directed breast biopsy and overpenetrated mammography

Silverstein, Melvin J.; Gamagami, Parvis; Rosser, Robert J.; Gierson, Eugene D.; Colburn, William J.; Handel, Neal; Fingerhut, Aaron G.; Lewinsky, Bernard S.; Hoffman, Robert S.; Waisman, James

doi:10.1002/1097-0142(19870215)59:4<715::aid-cncr2820590409>3.0.co;2-c

Cited by 92 publications

(22 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was found in only two women over 50 years of age and this small incidence is in keeping with a recent report that showed the average age of patients with fibroadenoma is 50 years. 18 Mammograms were done because of symptoms in 99% of the women, indicating that neither local practicing physicians nor women at risk are aware or convinced of the importance of screening mammography. The American Cancer Society recommends that, in addition to regular breast and physical examinations, a baseline mammogram should be obtained in all women between the ages of 35 and 39 years with subsequent mammograms taken every 1 to 2 years in women aged 40 to 49 years and every year in women aged 50 years and older.…”

Section: Discussionmentioning

confidence: 99%

Retrospective Appraisal of 300 Consecutive Mammograms

et al. 1990

View full text Add to dashboard Cite

Based on certain selection criteria, 300 consecutive mammograms were reviewed, together with other relevant clinical and pathological data. The median age (± SD) of eligible women was 36.11 (± 11.2 years). Saudis represented 65% (196 women) of the study population and non-Saudis 35% (104 women). Seventy-three women (24%) had normal findings but fibrocystic disease was found in 177 (59%), invasive carcinoma in 26 (9%), and fibroadenoma in 24 (8%). Ninety-nine percent of the mammograms were ordered in women who had had breast symptoms for several months. Cancer patients had been aware of their breast lump for a mean of 8.04 ± 2.11 (SD) months. All cancers were invasive and most (92.3%) were advanced at diagnosis. Among the 177 patients with fibrocystic disease, only six (3%) were found to have atypical hyperplasia, but its prevalence is lower than that reported recently. Agreement between final and mammographic diagnoses was significant (P = 0.027). Also shown were the high specificity (79%), sensitivity (100%), and accuracy (89%) of mammograms in cancer patients. The ability of mammography to show malignancy was proven by multiple regression analysis. Our data taken from a sample of women seen at a tertiary care facility shed some light on the pattern of breast disorders in our patient population. The data should be utilized in the planning for a national breast cancer early detection program.AY El-Hassan, FA Al-Mulhim, EM Ibrahim, MS Al-Awami, Retrospective Appraisal of 300 Consecutive Mammograms. 1990; 10(3): 285-290 Radiographic examination of the breast is not a new procedure. The first mammographie study was made by Salomon in 1913 and the first clinical paper on the subject was published in 1930 by Warren.1 Since then, mammography has proved its value in the diagnosis of various breast diseases. However, it was not until 1956 that the procedure was introduced for the mass screening of healthy women in the early detection of breast cancer. 2Analysis of data derived from these major screening projects has shown an unequivocal benefit for women older

show abstract

Section: Discussionmentioning

confidence: 99%

Retrospective Appraisal of 300 Consecutive Mammograms

et al. 1990

View full text Add to dashboard Cite

show abstract

“…3,4 The fact that no screening program is performed in our country is most likely the principal cause of the low prevalence of DCIS in China. 3,4 The fact that no screening program is performed in our country is most likely the principal cause of the low prevalence of DCIS in China.…”

Section: Discussionmentioning

confidence: 99%

Recognizing breast ductal carcinoma in situ on fine‐needle aspiration: A diagnostic dilemma

Zhang

Zhao

et al. 2013

Diagnostic Cytopathology

View full text Add to dashboard Cite

In this study, we evaluated cytomorphologic features of different subgroups of ductal carcinoma in situ (DCIS); we compared seven cytologic features between DCIS and invasive ductal carcinoma (IDC) aspirates to determine whether diagnosis of stromal invasion can be made based on fine-needle aspiration (FNA) findings. There were 142 cases of DCIS and 1,978 cases of IDC enrolled in our study. FNA analysis revealed 80.3% sensitivity for DCIS and 94.7% sensitivity for IDC. High and intermediate grade DCIS exhibited marked nuclear abnormality (92.1% vs. 35.7%, 30.0%; P1 < 0.001, P2 < 0.001) and necrosis (69.7% vs. 0%, 10.0%; P1 < 0.001, P2 = 0.001) in a higher percentage of cases compared to low grade DCIS and intraductal/intracystic papillary carcinoma. The rates of background macrophages (71.3% for DCIS and 21.9% for IDC, P < 0.001) and extensive necrosis (54.0% for DCIS and 16.7% for IDC, P < 0.001) were significantly higher in DCIS compared to IDC. Lymphocytes were observed in conjunction with tumor cells more frequently in IDC (81.3%) compared to DCIS (36.8%, P < 0.001). Stromal fragments associated with tumor cells were only observed in invasive lesions (11.9% micro-invasive DCIS and 52.1% IDC). Tubular structures were found exclusively in IDC (11.5%). Cytologic criteria for diagnosis of high and low grade DCIS are different. The suspicion of DCIS is raised when background macrophages and extensive necrosis are observed. Stromal invasion is suggested by FNA if lymphocytes are entwined around tumor cells or if stromal fragments associated with tumor cells or tubular structures are observed.

show abstract

“…Usually, a lesion of 3 cm or more was regarded as an indication for bracketing wire localization in our institution [10].…”

Section: Methodsmentioning

confidence: 99%